| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 9.4× | 13.3× | |
| Price / Book | 3.8× | 2.7× | |
| Price / Sales | 1.1× | 1.3× | |
| Price / Free cash flow | 26.9× | 11.3× | |
| EV / EBITDA | 7.4× | 6.5× | |
| Earnings yield | 10.7% | 7.5% | |
| Free cash flow yield | 3.7% | 2.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
GLKAR:GLAXOGlaxoSmithKline Pakistan Ltd · 🇵🇰 KAR | Rs 312.45 | +0.19% | $358.55M | 9.9× | 29.8% | −21.6% |
ABKAR:ABOTAbbott Laboratories (Pakistan) Ltd · 🇵🇰 KAR | Rs 944.39 | +1.11% | $330.12M | 11.5× | 25.2% | −21.3% |
HAKAR:HALEONHaleon Pakistan Ltd · 🇵🇰 KAR | Rs 684.36 | +0.88% | $286.7M | 12.5× | 43.1% | −24.0% |
HIKAR:HINOONHighnoon Laboratories Ltd · 🇵🇰 KAR | Rs 931.97 | +1.71% | $175.26M | 11.8× | 30.0% | −19.1% |
SEKAR:SEARLThe Searle Co Ltd · 🇵🇰 KAR | Rs 77.74 | −0.75% | $166.34M | 104.6× |
| 1.3% |
| −30.6% |
AGKAR:AGPAGP Ltd · 🇵🇰 KAR | Rs 168.38 | +4.11% | $163.5M | 12.1× | 24.2% | −16.3% |
HPKAR:HPLHoechst Pakistan Ltd · 🇵🇰 KAR | Rs 4,035.00 | +0.62% | $139.64M | 13.3× | 35.4% | −4.7% |
FEKAR:FEROZFerozsons Laboratories Ltd · 🇵🇰 KAR | Rs 335.22 | +0.67% | $52.26M | 18.6× | 6.3% | −17.3% |
CPKAR:CPHLCiti Pharma Ltd · 🇵🇰 KAR | Rs 61.66 | −0.61% | $51.17M | 15.9× | 8.2% | −30.6% |
BFKAR:BFBIOBF Biosciences Ltd · 🇵🇰 KAR | Rs 128.65 | −0.96% | $41.43M | 25.7× | 9.6% | −17.0% |
